PharmaResearch Co., Ltd. Stocks

PharmaResearch Co., Ltd., a biopharmaceutical company based in Seongnam, South Korea, was established in 1993. The firm offers a diverse portfolio of products, including pharmaceuticals, medical devices, and functional foods. Its product range features Re-An eye drops, designed to shield eyes from various types of corneal damage. For tissue regeneration, PharmaResearch provides the Rejuvenex injection, an activator for connective tissues such as ligaments, tendons, and skin, along with Rejuvenex cream, which promotes rapid wound healing. A significant portion of its offerings falls under the REJURAN brand, focusing on advanced skin care. This includes REJURAN HEALER, an intradermal injection enhancing skin elasticity, turgidity, and tonicity, complemented by Rejuran i and Rejuran s injections (administered intradermally or via cannula). The REJURAN line also extends to daily protective moisturizer, a specialized concentrate for sensitive and aging skin, healing eye gel, healing creams and masks, a UV-protective sunscreen, and a soothing recovery mask. Additionally, the company manufactures the D+CELL 350 TRA series, a comprehensive collection of rejuvenation and repair solutions, encompassing concentrated creams, intensive serums, activating facial toners, high-potency eye lifts, moisture balancers, masks, as well as hair and hydro products. Other notable items include the REJURAN tone-up booster and various medical devices, such as CLEVIEL prime plus and contour plus (both containing lidocaine), and CONJURAN medical devices. Diversifying its operations, PharmaResearch also produces functional foods marketed under the REJULINE, REJUSHINE, and REJULIGHT brand names. The company adopted its current name, PharmaResearch Co., Ltd., in April 2021, having previously been known as Pharma Research Products Co., Ltd.